Modulation of melphalan resistance in glioma cells with a peripheral benzodiazepine receptor ligand-melphalan conjugate

Journal of Medicinal Chemistry

Volumn 40, Issue 11, 1997, Pages 1726-1730

  Kupczyk Subotkowska, Lidia ^a   Siahaan, Teruna J ^a   Basile, Anthony S ^b   Friedman, Henry S ^c   Higgins, Patricia E ^d   Song, Di ^d   Gallo, James M ^d  

^a UNIVERSITY OF KANSAS   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR; MELPHALAN; MEMBRANE RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; BLOOD BRAIN BARRIER; BRAIN TUMOR; CELL SURFACE; DRUG SYNTHESIS; GENE THERAPY; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; RECEPTOR BINDING; TREATMENT PLANNING;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BENZODIAZEPINONES; BRAIN; BRAIN NEOPLASMS; CELL DEATH; DRUG RESISTANCE, NEOPLASM; GLIOMA; HUMANS; MELPHALAN; RATS; RECEPTORS, GABA-A; TUMOR CELLS, CULTURED;

EID: 0030919486     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960592p     Document Type: Article

References (29)

1. Brem, H.; Mahaley, M. S., Jr.; Vick, N. A.; Black, K. L.; Schold, S. C., Jr.; Burger, P. C.; Freidman, H.; Ciric, I. S.; Cozzens, T. W.; Kenealy, J. N. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J. Neurosurg. 1991, 74, 441-446.
2. Brem, H.; Piantadosi, S.; Burger, P. C.; Group, P. B. T. T. Intraoperative chemotherapy using biodegradable polymers: safety and effectiveness for recurrent glioma evaluated by a prospective, multi-institutional placebo-controlled clinical trial. Lancet 1995, 345, 1008-1012.
3. Weller, M.; Malipiero, U.; Rensing-Ehl, A.; Barr, P. J.; Fontana, A. Fas/APO-1 gene transfer for human malignant glioma. Cancer Res. 1995, 55, 2936-2944.
4. Felker, G. M.; Friedman, H. S.; Dolan, M. E.; Moschel, R. C.; Schold, S. C., Jr. Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Chemother. Pharmacol. 1993, 32, 471-476.
5. Skapek, S. X.; Colvin, O. M.; Griffith, O. W.; Groothius, D. R.; Colapinto, E. V.; Lee, Y.; Hilton, J.; Elion, G. B.; Bigner, D. D.; Friedman, H. S. Buthionine sulfoximine-mediated depletion of glutathione in intracranial human glioma-derived xenografts. Biochem. Pharmacol. 1988, 37, 4313-4317.
6. Black, K. L.; Ikezaki, K.; Toga, A. W. Imaging of brain tumors using peripheral benzodiazepine receptor ligands. J. Neurosurg. 1989, 71, 113-118.
7. Black, K. L.; Ikezaki, K.; Santori, E.; Becker, D. P.; Vinters, H. V. Specific high-affinity binding of peripheral benzodiazepine receptor ligands to brain tumors in rat and man. Cancer 1990, 65, 93-97.
8. Ikezaki, K.; Black, K. L.; Toga, A. W.; Santori, E. M.; Becker, D. P.; Smith, M. L. Imaging peripheral benzodiazepine receptors in brain tumors in rats: in vitro binding characteristics. J. Cerebral Blood Flow Metab. 1990, 10, 580-587.
9. Marangos, P. J.; Patel, J.; Boulenger, J.-P.; Clark-Rosenberg, R. Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864. Mol. Pharmacol. 1982, 22, 26-32.
10. Basile, A. S.; Skolnick, P. Subcellular localization of peripheral-type binding sites for benzodiazepine in rat brain. J. Neurochem. 1986, 46, 305-308.
11. Anholt, R. R. H.; Pedersen, P.; De Souza, E.; Snyder, S. The peripheral-type benzodiazepine receptor: localization to the mitochondrial outer membrane. J. Biol. Chem. 1986, 261, 576-583.
12. Ram, S.; Ehrenkaufer, R. E. A General Procedure for Mild and rapid Reduction of Aliphatic and aromatic Nitro Compounds Using Ammonium Formate as a Catalytic Hydrogen Transfer Agent. Tetrahedron Lett. 1984, 25, 3415-3418.
13. Appel, R. Tertiary Phosphane/Tetrachloromethane, a Versatile Reagent For Chlorination, Dehydration, and P-N Linkage. Angew. Chem., Int. Ed. Engl. 1975, 14, 801-811.
14. Sternback, L. H.; Fryer, R. I.; Metlesics, W.; Reeder, E.; Sach, G.; Saucy, G.; Stempel, A. Quinazolines and 1,4-Benzodiazepines VI. Halo-, Methyl-, and Methoxy-substituted 1,3-Dihydro-5-phenyl-2H-1,4-benzodiazepin-2-ones. J. Org. Chem. 1962, 27, 3788-3796.
15. Wang, J. K. T.; Taniguchi, T.; Spector, S. Structural requirements for the binding of benzodiazepines to their peripheral-type sites. Mol. Pharmacol. 1984, 25, 349-351.
16. Olson, J. M. M.; Junck, L.; Young, A. B.; Penney, J. B.; Mancini, W. R. Isoquinoline and peripheral-type benzodiazepine binding in gliomas: Implications for diagnostic imaging. Cancer Res. 1988, 48, 5837-5841.
17. Basile, A. S.; Klein, D. C.; Skolnick, P. Characterization of benzodiazepine receptors in the bovine pineal gland: Evidence for the presence of an atypical binding site. Mol. Brain Res. 1986, 1, 127-135.
18. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82, 1107-1112.
19. Buttke, T. M.; McCubrey, J. A.; Owen, T. C. Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines. J. Immunol. Methods 1993, 157, 233-340.
20. Rubinstein, L. V.; Shoemaker, R. H.; Paull, K. D.; Simon, R. M.; Tosini, K.; Skehan, P.; Scudiero, D. A.; Monks, A.; Boyd, M. R. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J. Natl. Cancer Inst. 1990, 82, 1113-1118.
21. Rosenberg, M. C.; Colvin, O. M.; Griffith, O. W.; Bigner, S. H.; Elion, G. B.; Horton, J. K.; Lilley, E.; Bigner, D. D.; Friedman, H. S. Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion. Cancer Res. 1989, 49, 6917-6922.
22. Phillips, P. C. Antineoplastic drug resistance in brain tumors. Neurol. Clin. 1991, 9, 383-404.
23. Friedman, H. S.; Dolan, M. E.; Kaufmann, S. H.; Colvin, O. M.; Griffith, O. W.; Moschel, R. C.; Schold, S. C.; Bigner, D. D.; Ali-Osman, F. Elevated DNA polymerase a, DNA polymerase B, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosourease and topotecan. Cancer Res. 1994, 54, 3487-3493.
24. Kupczyk-Subotkowska, L.; Tamura, K.; Pal, D.; Sakaeda, T.; Siahaan, T. J.; Stella, V. J.; Borchardt, R. T. Derivative of melphalan designed to enhance drug accumulation in cancer cells. J. Drug Targeting, accepted for publication.
25. Greig, N. H.; Momma, S.; Sweeney, D. J.; Rapoport, S. I. Facilitated transport of melphalan at the blood-brain barrier by the large neutral amino acid carrier system. Cancer Res. 1987, 47, 1571-1576.
26. Erlenmeyer, E.; Lipp, A. Synthese des Tyrosins. Ann. Chem. 1883, 219, 161-233.
27. Bergel, F.; Stock, J. A. Cyto-active Amino-acid and Peptide Derivatives. Part I. Substituted phenylalanines. J. Chem. Soc. 1954, 2409-2417.
28. Basile, A. S.; Skolnick, P. Tissue specific regulation of "peripheral-type" benzodiazepine receptor density after chemcial sympathectomy. Life Sci. 1988, 42, 273-283.
29. CellTiter 96 AQueous Assay; Promega: Madison, WI, 1994.